Original Research: COPD |

Implantable Cardioverter-Defibrillators in Patients With COPDImplantable Cardioverter-Defibrillators in COPD

Niyada Naksuk, MD; Ken M. Kunisaki, MD, FCCP; David G. Benditt, MD; Venkatakrishna Tholakanahalli, MD; Selcuk Adabag, MD
Author and Funding Information

From the Division of Cardiology, Veterans Administration Medical Center, and Department of Medicine, University of Minnesota, Minneapolis, MN.

Correspondence to: Selcuk Adabag, MD, Veterans Administration Medical Center, Section of Cardiology (111 C), 1 Veterans Dr, Minneapolis, MN 55417; e-mail: adaba001@umn.edu

Part of this article has been presented in abstract form at the Heart Rhythm Society 33rd Annual Scientific Sessions, May 9-12, 2012, Boston, Massachusetts.

Funding/Support: The authors have reported to CHEST that no funding was received for this study.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.

Chest. 2013;144(3):778-783. doi:10.1378/chest.12-1883
Text Size: A A A
Published online

Background:  COPD is a common comorbidity in heart failure. The efficacy of implantable cardioverter-defibrillator (ICD) therapy has not been determined in patients with heart failure and COPD.

Methods:  We examined the incidence of ICD shocks and mortality in 628 consecutive patients who underwent defibrillator implantation at the Minneapolis Veterans Affairs Medical Center from 2006 to 2010.

Results:  The mean age of the patients was 67 ± 10 years, and 99% were men. Patients with COPD (n = 246 [39%]) were functionally more limited (P < .0001) and more likely to have an ICD for primary prevention of sudden death (P = .04) than those without COPD. Over a median 4.1 years (interquartile range [IQR] 2.2-5.7) of follow-up, patients with COPD had a higher incidence of appropriate shocks than those without COPD (29% vs 17%; P < .0001), whereas the incidence of inappropriate shocks was similar (9% vs 10%, P = .61). In multivariable analysis, COPD was associated with a twofold increase in the odds of an appropriate ICD shock (95% CI, 1.3-2.9; P = .001). Incidence of ICD shocks did not vary with severity of COPD. Although all-cause mortality was higher in patients with COPD than in those without COPD (29% vs 21%, P = .029), 1-year mortality (5.3% vs 2.6%, P = .08) and the average time from first appropriate ICD shock to death was comparable (median, 2.3 [IQR, 1.2-4.4] vs 2.8 [IQR, 1.4-5.3] years; P = .29).

Conclusions:  Patients with COPD have a higher incidence of ICD shocks than those without COPD and appear to benefit from ICD therapy.

Figures in this Article

Sign In to Access Full Content

Want to Purchase a Subscription?

New to CHEST? Become an ACCP member to receive a full subscription to both the print and online editions.
Want to access your Institution's subscription?
Sign in to your individual user account while you are actively authenticated on this website via your institution (Learn more about institutional authentication). We will then sustain your personal access to their content/subscription for 90 days, after which you can repeat this process.

Sign In to Access Full Content

Want to Purchase a Subscription?

New to CHEST? Become an ACCP member to receive a full subscription to both the print and online editions.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543